Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Peter Saranchuk"'
Autor:
David Heiden, NiNi Tun, Ernest Maningding, Matthew Heiden, Jennifer Rose-Nussbaumer, Khin Nyein Chan, Tamara Khizniak, Alexandra Yakubenko, Susan Lewallen, Jeremy D Keenan, Peter Saranchuk
Publikováno v:
Bulletin of the World Health Organization, Vol 92, Iss 12, Pp 903-908 (2014)
Problem Acquired immunodeficiency syndrome (AIDS)-related cytomegalovirus (CMV) retinitis continues to be a neglected source of blindness in resource-poor settings. The main issue is lack of capacity to diagnose CMV retinitis in the clinical setting
Externí odkaz:
https://doaj.org/article/1aac4f3a16c84f3bb60a2406304ca3c3
Autor:
Samsuddin Khan, Mrinalini Das, Aristomo Andries, Alaka Deshpande, Homa Mansoor, Peter Saranchuk, Petros Isaakidis
Publikováno v:
Global Health Action, Vol 7, Iss 0, Pp 1-6 (2014)
Background: There are limited data on the failure of second-line antiretroviral therapy (ART) and the use of third-line ART in people living with HIV in resource-limited settings. Since 2011, the Médecins Sans Frontières (MSF) HIV/tuberculosis prog
Externí odkaz:
https://doaj.org/article/13bbebd12c934923b6f53b96d41fd70d
Autor:
Alpa Dalal, Akshay Pawaskar, Mrinalini Das, Ranjan Desai, Pralhad Prabhudesai, Prashant Chhajed, Sujeet Rajan, Deepesh Reddy, Sajit Babu, T K Jayalakshmi, Peter Saranchuk, Camilla Rodrigues, Petros Isaakidis
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0116798 (2015)
BACKGROUND:While the high burden of multidrug-resistant tuberculosis (MDR-TB) itself is a matter of great concern, the emergence and rise of advanced forms of drug-resistance such as extensively drug-resistant TB (XDR-TB) and extremely drug-resistant
Externí odkaz:
https://doaj.org/article/bb0aeac309b448849684638b5fe93700
Autor:
Elisa Ardizzoni, Emmanuel Fajardo, Peter Saranchuk, Martina Casenghi, Anne-Laure Page, Francis Varaine, Cara S Kosack, Pamela Hepple
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144656 (2015)
The Xpert® MTB/RIF (Xpert) is an automated molecular test for simultaneous detection of tuberculosis (TB) and rifampicin resistance, recommended by the World Health Organization as the preferred diagnostic method for individuals presumed to have mul
Externí odkaz:
https://doaj.org/article/08ba2c23b1174c3593565b9af88ef786
Publikováno v:
The Pan African Medical Journal, Vol 19, Iss 136 (2014)
Introduction: Malawi has one of the highest HIV prevalences in Sub-Saharan Africa. The rate of eligible HIV-infected people being initiated on antiretroviral therapy (ART) and retained in HIV care is currently far from adequate. Consequently, many pe
Externí odkaz:
https://doaj.org/article/bad69a032a7a4ed187882d094fab757c
Autor:
David Heiden, Peter Saranchuk, NiNi Tun, Bertrand Audoin, Jen Cohn, Nicolas Durier, Gary Holland, W Lawrence Drew, Ellen ‘t Hoen
Publikováno v:
The Lancet Global Health, Vol 2, Iss 2, Pp e76-e77 (2014)
Externí odkaz:
https://doaj.org/article/ea6244bdabfc47dda3c03c4c08466bd6
Autor:
Petros Isaakidis, Mrinalini Das, Ajay M V Kumar, Christopher Peskett, Minni Khetarpal, Arun Bamne, Balkrishna Adsul, Mamta Manglani, Kuldeep Singh Sachdeva, Malik Parmar, Avinash Kanchar, B B Rewari, Alaka Deshpande, Camilla Rodrigues, Anjali Shetty, Lorraine Rebello, Peter Saranchuk
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110461 (2014)
BackgroundDrug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, no countrywide prevalence data are available. The burden of DR-TB in HIV-co-infected patients is likewise unknown. Undiagnosed and untreated
Externí odkaz:
https://doaj.org/article/9b180a4bdd8642e8bffbb36844b24ca7
Autor:
Mrinalini Das, Petros Isaakidis, Rahul Shenoy, Rey Anicete, Hemant Kumar Sharma, Imyangluba Ao, Kaikho Osah, Homa Mansoor, Peter Saranchuk, Sunita Abraham
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e108186 (2014)
BACKGROUND: Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' areas of north-east India have poor access to health se
Externí odkaz:
https://doaj.org/article/d93de81f4eb4437b8a6824f2715df965
Autor:
Petros Isaakidis, Roma Paryani, Samsuddin Khan, Homa Mansoor, Mamta Manglani, Asmaa Valiyakath, Peter Saranchuk, Jennifer Furin
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68869 (2013)
BackgroundLittle is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-co-infected adolescents. This study aimed to present the intermediate outcomes of HIV-infected adolescents aged 10-19 years receiving second-line anti-T
Externí odkaz:
https://doaj.org/article/45162a06fa0043d28595f43cab290880
Autor:
Aristomo Andries, Petros Isaakidis, Mrinalini Das, Samsuddin Khan, Roma Paryani, Chitranjan Desai, Alpa Dalal, Homa Mansoor, Reena Verma, Dolorosa Fernandes, Giovanni Sotgiu, Giovanni B Migliori, Peter Saranchuk
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e78313 (2013)
BACKGROUND: Adverse events (AEs) among HIV-infected patients with multidrug-resistant tuberculosis (MDR-TB) receiving anti-TB and antiretroviral treatments (ART) are under-researched and underreported. Hypothyroidism is a common AE associated with et
Externí odkaz:
https://doaj.org/article/8941155e470c470f9dd933a8139f92d6